Elevance Health, Inc. (ELV)
Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates
Elevance Health (ELV) came out with quarterly earnings of $10.12 per share, beating the Zacks Consensus Estimate of $9.99 per share. This compares to earnings of $9.04 per share a year ago.
Here's Why Elevance Health (ELV) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Can Elevance Health (ELV) Beat Q2 Earnings on Lower Expenses?
Elevance Health's (ELV) second-quarter results are likely to be aided by improved product revenues, commercial fee-based membership growth, and lower expenses.
What Analyst Projections for Key Metrics Reveal About Elevance Health (ELV) Q2 Earnings
Beyond analysts' top -and-bottom-line estimates for Elevance Health (ELV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Elevance Health (ELV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Elevance Health (ELV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Elevance Health (ELV) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The 3 Healthiest Healthcare Stocks to Buy for a Huge Dose of Profits
The healthcare sector is often considered a defensive play, with healthcare stocks to buy offering stability and growth potential even during economic downturns. The sector's strength is driven by an aging global population, rising healthcare expenditures, and advancements in medical technology.
Elevance Health (ELV) Rallies 11.8% YTD: More Room to Run?
Elevance Health's (ELV) performance benefits from new contract wins, a strong Carelon segment and recovering Medicaid business.
3 Healthcare Stocks to Buy as Medicare Goes Private
While it's never a bad time to look for healthcare stocks to buy, the privatization of Medicare has created some very prosperous businesses. As a result, it's not necessarily great for consumers.
Here's Why Elevance Health (ELV) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Elevance exec says Medicaid attrition has changed mix of members
Elevance Health executive Peter Haytaian said on Wednesday that a decrease in the number of people eligible for its Medicaid plans this year, as well as changes the company made in where it operates those plans, shifted its balance of healthy and sick members.
